Only people who have personally completed the full US IPO cycle deserve your listing timeline. Ten more rule-side advisors from the SEC, Nasdaq, NYSE and HKEX bring the regulator's perspective into every plan.
Every one of them has run deals on a Wall Street desk — and sat on the other side of the table for Chinese issuers.
Under client and candidate confidentiality agreements, surnames and photographs are shown in abbreviated form. Full profiles are provided once an NDA is in place.
Our bankers get the deal done; our rule-side advisors make sure it clears review the first time — they wrote the rules and vetted the deals, and now they sit on your side.
The institutions above reflect the advisors' past employment only. They do not imply any partnership, authorisation or endorsement by the SEC, Nasdaq, NYSE, HKEX, PCAOB or FINRA. Names and photographs are likewise anonymised under confidentiality agreements.
Twenty people: ten Western partners from Goldman Sachs, Morgan Stanley, J.P. Morgan, Citi, UBS and the Big Four, plus ten regulatory advisers with SEC, Nasdaq, NYSE, HKEX, PCAOB and FINRA backgrounds.
Goldman Sachs, Morgan Stanley, J.P. Morgan, Citi, UBS and other international banks, plus the Big Four. Every one of them has completed a full US IPO cycle, not just a single stage of one.
Different roles: partners take on and deliver the mandate, while regulatory advisers make the regulatory position and review focus clear. An adviser's background is stated only to show where they worked; it implies no relationship between those institutions and 51CFO.
Brian Tian. The public identity is verifiable by name, and the contact address is brian@51cfo.team.
The practice is US-market only, and the team works to US filing and trading hours. Clients in mainland China can book a 30-minute route diagnosis by WeChat (13392476067) or email, and we reply within 24 hours.
A 30-minute listing-route diagnosis: we assess which route fits you, the timetable and the gaps on your team, and set out the next steps. Free, and fully confidential.